-
The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulator.
Toxicology and applied pharmacology 20160401
-
Effects of lisdexamfetamine in a rat model of binge-eating.
Journal of psychopharmacology (Oxford, England) 20151201
-
Atrazine enhances progesterone production through activation of multiple signaling pathways in FSH-stimulated rat granulosa cells: evidence for premature luteinization.
Biology of reproduction 20141101
-
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network.
eLife 20140101
-
Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
The Biochemical journal 20130901
-
Quercetin acutely relaxes airway smooth muscle and potentiates β-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCβ and PDE4.
American journal of physiology. Lung cellular and molecular physiology 20130901
-
Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs.
Advances in experimental medicine and biology 20130101
-
Phosphodiesterase 4-targeted treatments for autoimmune diseases.
BMC medicine 20130101
-
Role of yessotoxin in calcium and cAMP-crosstalks in primary and K-562 human lymphocytes: the effect is mediated by anchor kinase A mitochondrial proteins.
Journal of cellular biochemistry 20121201
-
Phosphodiesterases as therapeutic targets for Alzheimer's disease.
ACS chemical neuroscience 20121121
-
Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4.
Toxicology and applied pharmacology 20121115
-
Regio- and enantioselective palladium-catalyzed allylic alkylation of nitromethane with monosubstituted allyl substrates: synthesis of (R)-rolipram and (R)-baclofen.
The Journal of organic chemistry 20121019
-
Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder.
Biological psychiatry 20121001
-
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study.
Urology 20121001
-
Evidence for global reduction in brain cyclic adenosine monophosphate signaling in depression.
Biological psychiatry 20121001
-
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
Journal of the neurological sciences 20120915
-
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
Journal of medicinal chemistry 20120913
-
Various phosphodiesterase activities in different regions of the heart alter the cardiac effects of nitric oxide.
Journal of cardiovascular pharmacology 20120901
-
Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair.
Journal of controlled release : official journal of the Controlled Release Society 20120810
-
Cyclic AMP increases COX-2 expression via mitogen-activated kinase in human myometrial cells.
Journal of cellular and molecular medicine 20120701
-
Working memory in the aged Ts65Dn mouse, a model for Down syndrome.
Behavioural brain research 20120615
-
Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA.
Inflammatory bowel diseases 20120601
-
Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
The Journal of pharmacology and experimental therapeutics 20120601
-
Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.
The Journal of physiology 20120601
-
Attenuation by sphingosine-1-phosphate of rat microvessel acute permeability response to bradykinin is rapidly reversible.
American journal of physiology. Heart and circulatory physiology 20120515
-
Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
The Prostate 20120515
-
Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.
American journal of respiratory cell and molecular biology 20120501
-
Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.
Pharmacology, biochemistry, and behavior 20120501
-
Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
Bioorganic & medicinal chemistry letters 20120401
-
C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
Bioorganic & medicinal chemistry 20120401
-
4,4-Dimethyl-2-[3-nitro-2-phenyl-1-(phenyl-sulfan-yl)prop-yl]-4,5-dihydro-1,3-oxazole.
Acta crystallographica. Section E, Structure reports online 20120401
-
Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Neuropharmacology 20120301
-
PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis.
Translational psychiatry 20120301
-
Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Life sciences 20120227
-
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.
Cell 20120203
-
A re-assessment of a combinatorial treatment involving Schwann cell transplants and elevation of cyclic AMP on recovery of motor function following thoracic spinal cord injury in rats.
Experimental neurology 20120201
-
Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
Psychopharmacology 20120201
-
Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
European journal of medicinal chemistry 20120201
-
Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
PloS one 20120101
-
Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization.
International journal of nanomedicine 20120101
-
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20120101
-
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury.
PloS one 20120101
-
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Journal of medicinal chemistry 20111208
-
Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2.
Bioorganic & medicinal chemistry letters 20111201
-
Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
Psychopharmacology 20111101
-
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Human molecular genetics 20111101
-
Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20111101
-
NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
American journal of physiology. Lung cellular and molecular physiology 20111001
-
Safety and efficacy of new 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine analogs as potential phosphodiesterase-4 inhibitors in NIH-3T3 mouse fibroblastic cells.
Chemical biology & drug design 20110901
-
Phosphodiesterase-4 inhibition reduces proteolysis and atrogenes expression in rat skeletal muscles.
Muscle & nerve 20110901
-
Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation, and behavior in the forced-swim test.
The Journal of pharmacology and experimental therapeutics 20110801
-
A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI.
Experimental neurology 20110701
-
2-(2-Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats.
Free radical biology & medicine 20110615
-
Partially purified extract and viscolin from Viscum coloratum attenuate airway inflammation and eosinophil infiltration in ovalbumin-sensitized mice.
Journal of ethnopharmacology 20110601
-
Effect of phoshpodiesterase 4 (PDE4) inhibibtors on eotaxin expression in humen bronchial epithelial cells.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20110601
-
Epac-mediated cAMP-signalling in the mouse model of Rett Syndrome.
Neuropharmacology 20110501
-
Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3/PDE4 inhibition in human alveolar macrophages.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20110401
-
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.
The Journal of biological chemistry 20110304
-
Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage.
Immunopharmacology and immunotoxicology 20110301
-
Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.
Investigative ophthalmology & visual science 20110301
-
Asymmetric synthesis of β-substituted γ-lactams via rhodium/diene-catalyzed 1,4-additions: application to the synthesis of (R)-baclofen and (R)-rolipram.
Organic letters 20110218
-
Soluble adenylyl cyclase mediates bicarbonate-dependent corneal endothelial cell protection.
American journal of physiology. Cell physiology 20110201
-
Beta-adrenergic stimulation contributes to maintenance of endothelial barrier functions under baseline conditions.
Microcirculation (New York, N.Y. : 1994) 20110201
-
Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.
Microcirculation (New York, N.Y. : 1994) 20110201
-
PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110201
-
Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20110105
-
Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28.
PloS one 20110101
-
Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio.
Journal of biomedical science 20110101
-
Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101
-
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
Current radiopharmaceuticals 20110101
-
Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
Clinical hemorheology and microcirculation 20110101
-
Improving the relaxing effect of terbutaline with phosphodiesterase inhibitors: studies on pregnant rat uteri in vitro.
Life sciences 20101218
-
Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils.
The European respiratory journal 20101201
-
Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides.
Urology 20101201
-
Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C.
The Biochemical journal 20101115
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit.
Genes & development 20101015
-
Synthesis and biological activity of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors.
Journal of medicinal chemistry 20101014
-
Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin.
Microbial pathogenesis 20101001
-
p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways.
Cellular signalling 20101001
-
Genistein, a competitive PDE1-4 inhibitor, may bind on high-affinity rolipram binding sites of brain cell membranes and then induce gastrointestinal adverse effects.
European journal of pharmacology 20100915
-
Bronchodilatory effect of Acorus calamus (Linn.) is mediated through multiple pathways.
Journal of ethnopharmacology 20100915
-
Methylxanthine reversal of opioid-evoked inspiratory depression via phosphodiesterase-4 blockade.
Respiratory physiology & neurobiology 20100731
-
Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
European journal of pharmacology 20100725
-
Rolipram and SP600125 suppress the early increase in PTP1B expression during cerulein-induced pancreatitis in rats.
Pancreas 20100701
-
Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices.
European journal of pharmacology 20100610
-
Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100601
-
Perivascular fluid cuffs decrease lung compliance by increasing tissue resistance.
Critical care medicine 20100601
-
The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen species.
European journal of pharmacology 20100510
-
Type 4 phosphodiesterase plays different integrating roles in different cellular domains in pyramidal cortical neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20100428
-
Prostanoid TP receptor-mediated impairment of cyclic AMP-dependent vasorelaxation is reversed by phosphodiesterase inhibitors.
European journal of pharmacology 20100425
-
Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
International immunopharmacology 20100401
-
Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20100401
-
Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application.
Bioorganic & medicinal chemistry letters 20100401
-
The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.
Immunology 20100301
-
Phosphodiesterase type 4 inhibition does not restore ocular dominance plasticity in a ferret model of fetal alcohol spectrum disorders.
Alcoholism, clinical and experimental research 20100301
-
Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
European journal of pharmacology 20100210
-
Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways.
Fundamental & clinical pharmacology 20100201
-
Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats.
Synapse (New York, N.Y.) 20100201
-
A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.
Psychopharmacology 20100201
-
Synaptic adaptations of CA1 pyramidal neurons induced by a highly effective combinational antidepressant therapy.
Biological psychiatry 20100115
-
The type IV phosphodiesterase inhibitor rolipram disturbs expression and extinction of conditioned fear in mice.
Neuropharmacology 20100101
-
Effects of rolipram on U46619-induced contraction and cyclic nucleotide content in the porcine coronary artery.
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20100101
-
Various emetogens increase the secretion of salivary amylase in rats: a potential model in emesis research.
Journal of pharmacological sciences 20100101
-
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
Arthritis research & therapy 20100101
-
Elevated cAMP opposes (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium.
Molecular vision 20100101
-
The selective inhibition of type IV phosphodiesterase attenuates the severity of the acute pancreatitis in rats.
Digestive diseases and sciences 20091201
-
Evidence that corticotropin-releasing hormone modulates myometrial contractility during human pregnancy.
Endocrinology 20091201
-
Theophylline inhibits the differentiation of human monocyte into dendritic cell potentially via adenosine receptor antagonism.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20091201
-
Phosphodiesterase isozymes involved in regulating acid secretion in the isolated mouse stomach.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20091201
-
Sleep deprivation impairs cAMP signalling in the hippocampus.
Nature 20091022
-
Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
European journal of pharmacology 20091012
-
Activity-based therapies to promote forelimb use after a cervical spinal cord injury.
Journal of neurotrauma 20091001
-
The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens.
Psychopharmacology 20091001
-
Accelerating axon growth to overcome limitations in functional recovery after peripheral nerve injury.
Neurosurgery 20091001
-
Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown.
Journal of cellular physiology 20090901
-
The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
The Journal of pharmacology and experimental therapeutics 20090901
-
Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.
Peptides 20090901
-
Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats.
Respirology (Carlton, Vic.) 20090901
-
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
European journal of haematology 20090701
-
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors.
Bioorganic & medicinal chemistry letters 20090701
-
Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs.
Pulmonary pharmacology & therapeutics 20090601
-
PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
American journal of physiology. Lung cellular and molecular physiology 20090601
-
The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release.
British journal of pharmacology 20090601
-
Involvement of phosphodiesterase 4 in beta-adrenoceptor agonist-induced amylase release in parotid acinar cells.
Journal of oral science 20090601
-
Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
European journal of pharmacology 20090521
-
Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
Cellular signalling 20090501
-
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling.
Physiological genomics 20090501
-
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.
Bioorganic & medicinal chemistry letters 20090415
-
Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
Naunyn-Schmiedeberg's archives of pharmacology 20090401
-
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.
Molecular psychiatry 20090401
-
The type 4 phosphodiesterase inhibitors rolipram and YM976 facilitate recall of the weak version of the passive avoidance task in the day-old chick.
Pharmacology, biochemistry, and behavior 20090401
-
Semi-synthetic analogs of pinitol as potential inhibitors of TNF-alpha cytokine expression in human neutrophils.
Bioorganic & medicinal chemistry letters 20090401
-
Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury.
Experimental neurology 20090401
-
Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury.
The journal of spinal cord medicine 20090401
-
Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.
Journal of medicinal chemistry 20090326
-
PDE type-4 inhibition increases L-type Ca(2+) currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells.
Pflugers Archiv : European journal of physiology 20090301
-
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
The European journal of neuroscience 20090301
-
Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats.
Canadian journal of physiology and pharmacology 20090301
-
ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
Immunology letters 20090221
-
Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor.
Pharmacology, biochemistry, and behavior 20090201
-
Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with beta2-mimetic on oxytocin-induced contractions in pregnant myometrium.
The journal of obstetrics and gynaecology research 20090201
-
Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
Glia 20090115
-
Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
BJU international 20090101
-
Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat.
Psychopharmacology 20090101
-
Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
International immunopharmacology 20090101
-
Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
British journal of pharmacology 20090101
-
Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
British journal of pharmacology 20090101
-
Pharmacology of a novel, orally active PDE4 inhibitor.
Pharmacology 20090101
-
Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors.
Journal of medicinal chemistry 20081225
-
Evidence that a protein kinase A substrate, small heat-shock protein 20, modulates myometrial relaxation in human pregnancy.
Endocrinology 20081201
-
Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis.
Experimental neurology 20081201
-
Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
Clinical cancer research : an official journal of the American Association for Cancer Research 20081201
-
mc1r Pathway regulation of zebrafish melanosome dispersion.
Zebrafish 20081201
-
Neuroenhancement: status quo and perspectives.
European archives of psychiatry and clinical neuroscience 20081101
-
Inhibitory effects of quercetin derivatives on phosphodiesterase isozymes and high-affinity [(3) H]-rolipram binding in guinea pig tissues.
Investigational new drugs 20081001
-
Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Digestive diseases and sciences 20081001
-
Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats.
Urology 20081001
-
Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Investigative ophthalmology & visual science 20081001
-
Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system.
Biotechnology journal 20081001
-
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Journal of medicinal chemistry 20080925
-
Curative effects of phosphodiesterase 4 inhibitors cilomilast, roflumilast, and rolipram in dermatitis mouse model.
Journal of dermatological science 20080901
-
Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.
The Journal of biological chemistry 20080815
-
Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: effect of exogenous nitric oxide.
Acta bio-medica : Atenei Parmensis 20080801
-
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Journal of medicinal chemistry 20080724
-
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors.
Bioorganic & medicinal chemistry letters 20080715
-
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients.
AIDS research and human retroviruses 20080701
-
Prolonged heterologous beta2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction.
American journal of physiology. Lung cellular and molecular physiology 20080601
-
cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium.
Histochemistry and cell biology 20080601
-
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease.
Neurobiology of disease 20080601
-
Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
European journal of pharmacology 20080531
-
Mechanisms of the relaxant effect of vardenafil in rat penile arteries.
European journal of pharmacology 20080531
-
Epi-cinchona based thiourea organocatalyst family as an efficient asymmetric Michael addition promoter: enantioselective conjugate addition of nitroalkanes to chalcones and alpha,beta-unsaturated N-acylpyrroles.
The Journal of organic chemistry 20080502
-
Synthesis, anti-bacterial, anti-asthmatic and anti-diabetic activities of novel N-substituted-2-(4-phenylethynyl-phenyl)-1H-benzimidazoles and N-substituted 2[4-(4,4-dimethyl-thiochroman-6-yl-ethynyl)-phenyl)-1H-benzimidazoles.
European journal of medicinal chemistry 20080501
-
PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Cellular signalling 20080501
-
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
British journal of pharmacology 20080501
-
Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.
Experimental neurology 20080501
-
Organocatalytic asymmetric total synthesis of (R)-rolipram and formal synthesis of (3S,4R)-paroxetine.
Organic letters 20080403
-
Administration of phosphodiesterase inhibitors and an adenosine A1 receptor antagonist induces phrenic nerve recovery in high cervical spinal cord injured rats.
Experimental neurology 20080401
-
Changes in the expression and dynamics of SHP-1 and SHP-2 during cerulein-induced acute pancreatitis in rats.
Biochimica et biophysica acta 20080401
-
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
European journal of pharmacology 20080317
-
Rhodanine derivatives as novel inhibitors of PDE4.
Bioorganic & medicinal chemistry letters 20080315
-
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques.
Psychopharmacology 20080301
-
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury.
The European respiratory journal 20080301
-
Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery.
American journal of physiology. Heart and circulatory physiology 20080301
-
Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Urology 20080301
-
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
Bioorganic & medicinal chemistry letters 20080215
-
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
British journal of pharmacology 20080201
-
Phosphodiesterase inhibitors--are they potential neuroleptic drugs?
Behavioural brain research 20080125
-
Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice.
Pharmacology 20080101
-
The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization.
American journal of physiology. Cell physiology 20080101
-
Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol.
Pulmonary pharmacology & therapeutics 20080101
-
Protein kinase C- and reactive oxygen species-dependent stimulation of intracellular cAMP in human eosinophils. The role of extracellular signal-regulated protein kinases.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20080101
-
Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats.
PloS one 20080101
-
Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock.
Critical care (London, England) 20080101
-
Microtubule motors regulate ISOC activation necessary to increase endothelial cell permeability.
The Journal of biological chemistry 20071130
-
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
European journal of pharmacology 20071114
-
Rh-catalyzed asymmetric hydrogenation of gamma-phthalimido-substituted alpha,beta-unsaturated carboxylic acid esters: an efficient enantioselective synthesis of beta-aryl-gamma-amino acids.
Organic letters 20071108
-
Analysis of vasodilator responses to peroxynitrite in the hindlimb vascular bed of the cat.
Journal of cardiovascular pharmacology 20071001
-
Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
European journal of pharmacology 20070910
-
[Recent progress in basic research concerning the management of benign prostatic hyperplasia].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20070901
-
High-performance liquid chromatographic separation of rolipram, bupivacaine and omeprazole using a tartardiamide-based stationary phase influence of flow rate and temperature on the enantioseparation.
Journal of chromatography. A 20070824
-
Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20070815
-
PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
The Journal of pharmacology and experimental therapeutics 20070801
-
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure.
British journal of pharmacology 20070801
-
Effect of sildenafil and rolipram on adrenergic responses in isolated human and monkey corpus cavernosum.
European urology 20070701
-
Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors.
Urology 20070701
-
The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.
Psychopharmacology 20070601
-
Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
Psychopharmacology 20070601
-
Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils.
American journal of veterinary research 20070601
-
Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.
Cancer research 20070601
-
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors.
Journal of enzyme inhibition and medicinal chemistry 20070601
-
Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
The Journal of biological chemistry 20070525
-
Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling.
Toxicology and applied pharmacology 20070515
-
The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia.
Stroke 20070501
-
A reporter gene assay for screening of PDE4 subtype selective inhibitors.
Biochemical and biophysical research communications 20070427
-
Elevated cAMP levels reverse Brucella melitensis-induced lipid peroxidation and stimulate IL-10 transcription in rats.
Research in veterinary science 20070401
-
Alterations in proteoglycan synthesis selectively impair FSH-induced particulate cAMP-phosphodiesterase 4 (PDE4) activation in immature rat Sertoli cells.
Biochimica et biophysica acta 20070401
-
The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
Naunyn-Schmiedeberg's archives of pharmacology 20070401
-
Rolipram, a phosphodiesterase 4 inhibitor, suppresses PGE2-induced osteoclast formation by lowering osteoclast progenitor cell viability.
Archives of pharmacal research 20070401
-
Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP.
The Journal of biological chemistry 20070323
-
Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat.
European journal of pharmacology 20070315
-
Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
European journal of pharmacology 20070308
-
Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
European urology 20070301
-
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity.
Neurobiology of disease 20070201
-
SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesterase.
Journal of medicinal chemistry 20070125
-
PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation.
Journal of immunology (Baltimore, Md. : 1950) 20070115
-
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
Neuroscience 20070105
-
Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary.
Molecular and cellular endocrinology 20070102
-
Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Pulmonary pharmacology & therapeutics 20070101
-
Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells.
American journal of physiology. Cell physiology 20070101
-
Preclinical assessment of curcumin as a potential therapy for B-CLL.
American journal of hematology 20070101
-
Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
Journal of the American Society of Nephrology : JASN 20070101
-
Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Journal of applied toxicology : JAT 20070101
-
In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
Nuclear medicine and biology 20070101
-
Antagonism of IL-4 signaling by a phosphodiesterase-4 inhibitor, rolipram, in human T cells.
International archives of allergy and immunology 20070101
-
Role of protein kinase C in substance P-induced synaptic depression in the nucleus accumbens in vitro.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20070101
-
Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Immunological investigations 20070101
-
Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Journal of musculoskeletal & neuronal interactions 20070101
-
Hormonal regulation of the contractile vacuole in Amoeba proteus: the role of cyclic nucleotide phosphodiesterases.
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20070101
-
The role of IFN-gamma in regulation of IFN-gamma-inducible protein 10 (IP-10) expression in lung epithelial cell and peripheral blood mononuclear cell co-cultures.
Respiratory research 20070101
-
Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium.
Naunyn-Schmiedeberg's archives of pharmacology 20061201
-
High sensitivity to neuromodulator-activated signaling pathways at physiological [K+] of confocally imaged respiratory center neurons in on-line-calibrated newborn rat brainstem slices.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20061115
-
Cyclic AMP-mediated regulation of the resting membrane potential in myelin-forming oligodendrocytes in the isolated intact rat optic nerve.
Experimental neurology 20061101
-
Delayed Nogo receptor therapy improves recovery from spinal cord contusion.
Annals of neurology 20061101
-
Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons.
Molecular and cellular neurosciences 20061101
-
Modulation of melatonin receptors and G-protein function by microtubules.
Journal of pineal research 20061101
-
Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Life sciences 20061012
-
Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds.
Behavioural brain research 20061002
-
Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells.
Cellular signalling 20061001
-
Salbutamol inhibits trypsin-mediated production of CXCL8 by keratinocytes.
Cytokine 20061001
-
Neuronal and smooth muscle receptors involved in the PACAP- and VIP-induced relaxations of the pig urinary bladder neck.
British journal of pharmacology 20060901
-
Analysis of change patterns of microcomputed tomography 3-dimensional bone parameters as a high-throughput tool to evaluate antiosteoporotic effects of agents at an early stage of ovariectomy-induced osteoporosis in mice.
Investigative radiology 20060901
-
Effects of the phosphodiestrase-4 inhibitor rolipram on lung resistance and inflammatory reaction in experimental asthma.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060901
-
Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
Neuroscience letters 20060814
-
Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice.
FEBS letters 20060724
-
Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats.
Biochemical and biophysical research communications 20060721
-
Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors.
Life sciences 20060717
-
Hydraulic conductance of pulmonary microvascular and macrovascular endothelial cell monolayers.
American journal of physiology. Lung cellular and molecular physiology 20060701
-
Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
Brain research 20060622
-
Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.
Life sciences 20060620
-
Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats.
Psychopharmacology 20060601
-
ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.
Journal of chemical neuroanatomy 20060601
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery.
European journal of pharmacology 20060424
-
Nitric oxide induces phosphodiesterase 4B expression in rat pulmonary artery smooth muscle cells.
American journal of physiology. Lung cellular and molecular physiology 20060401
-
Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action.
Neurobiology of learning and memory 20060301
-
Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.
The Biochemical journal 20060301
-
Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Experimental biology and medicine (Maywood, N.J.) 20060301
-
Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
European journal of pharmacology 20060217
-
Mechanisms of rolipram-induced increase in the incidence of mammary adenocarcinoma: histopathological study of a 104-week oral carcinogenicity study in female Sprague-Dawley rats.
Archives of toxicology 20060201
-
Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
The Journal of pharmacology and experimental therapeutics 20060201
-
Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.
British journal of pharmacology 20060201
-
Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.
The Journal of biological chemistry 20060113
-
TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
Molecular and biochemical parasitology 20060101
-
An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals.
Synapse (New York, N.Y.) 20060101
-
Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
Pulmonary pharmacology & therapeutics 20060101
-
Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
British journal of pharmacology 20060101
-
Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD.
Current medicinal chemistry 20060101
-
[Effect of phosphodiestrase 4 inhibitor (rolipram) on experimental allergic asthma-guinea pig model].
Pneumonologia i alergologia polska 20060101
-
Mitogen-activated protein kinase-mediated reinforcement of hippocampal early long-term depression by the type IV-specific phosphodiesterase inhibitor rolipram and its effect on synaptic tagging.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20051116
-
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Neurobiology of disease 20051101
-
Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Psychopharmacology 20051001
-
The pivotal role of cytokines in muscle wasting during cancer.
The international journal of biochemistry & cell biology 20051001
-
Pharmacological studies on mechanisms of aminophylline-induced seizures in rats.
Indian journal of experimental biology 20051001
-
Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20050928
-
An Aplysia type 4 phosphodiesterase homolog localizes at the presynaptic terminals of Aplysia neuron and regulates synaptic facilitation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20050928
-
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
Cellular signalling 20050901
-
Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
Molecular reproduction and development 20050801
-
Effects of rolipram on induction of action potential bursts in central snail neurons.
Experimental neurology 20050801
-
Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal transduction and regulation of mesenteric postcapillary fluid leak.
The Journal of trauma 20050801
-
[Evaluation methods for the discriminative stimulus and possible mechanisms of discriminative stimulus effects of methamphetamine in the rat].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20050701
-
Type 4 phosphodiesterase inhibition impairs detection of low odor concentrations in mice.
Behavioural brain research 20050620
-
Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes.
Journal of immunology (Baltimore, Md. : 1950) 20050615
-
Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Biochemistry 20050614
-
Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates aspirin-induced gastric mucosal injury in rats.
Digestive diseases and sciences 20050601
-
Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
European journal of pharmacology 20050509
-
Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability: determinants of the vascular leak site.
Circulation research 20050429
-
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
American journal of physiology. Heart and circulatory physiology 20050401
-
Airway function and reactivity, leukocyte influx and nitric oxide after inoculation with parainfluenza-3 virus: effects of dexamethasone or rolipram.
International immunopharmacology 20050401
-
Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
Bioorganic & medicinal chemistry letters 20050401
-
Rolipram attenuates MK-801-induced deficits in latent inhibition.
Behavioral neuroscience 20050401
-
Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20050401
-
Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium.
The Journal of biological chemistry 20050304
-
Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
Medicinal research reviews 20050301
-
Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.
Yonsei medical journal 20050227
-
8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors.
Journal of medicinal chemistry 20050224
-
Synthesis of 4-aryl-2-pyrrolidones and beta-aryl-gamma-amino-butyric acid (GABA) analogues by Heck arylation of 3-pyrrolines with arenediazonium tetrafluoroborates. Synthesis of (+/-)-rolipram on a multigram scale and chromatographic resolution by semipreparative chiral simulated moving bed chromatography.
The Journal of organic chemistry 20050204
-
Effect of rolipram on relative 14C-deoxyglucose uptake in inflammatory lesions and skeletal muscle.
European journal of nuclear medicine and molecular imaging 20050201
-
Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Biochemical pharmacology 20050201
-
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 20050115
-
The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
Pulmonary pharmacology & therapeutics 20050101
-
Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
Journal of gastroenterology and hepatology 20050101
-
Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase.
Pulmonary pharmacology & therapeutics 20050101
-
A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
Nephron. Experimental nephrology 20050101
-
Crystallization of cyclic nucleotide phosphodiesterases.
Methods in molecular biology (Clifton, N.J.) 20050101
-
Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation.
Respiratory research 20050101
-
Potentiation and prolongation of long-term odor memory in neonate rats using a phosphodiesterase inhibitor.
Neuroscience 20050101
-
An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors.
The Journal of infectious diseases 20041215
-
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes.
Molecular pharmacology 20041201
-
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes.
Cellular signalling 20041201
-
Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4.
Journal of medical microbiology 20041201
-
Synthesis and potential anti-inflammatory activity of some tetrahydrophthalazinones.
Journal of enzyme inhibition and medicinal chemistry 20041201
-
Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
Life sciences 20041119
-
The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types.
Endocrinology 20041101
-
cAMP response element-binding protein activation in ligation preconditioning in neonatal brain.
Annals of neurology 20041101
-
Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
Journal of cardiovascular pharmacology 20041101
-
Persistent accumulation of calcium/calmodulin-dependent protein kinase II in dendritic spines after induction of NMDA receptor-dependent chemical long-term potentiation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20041020
-
Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C.
European journal of pharmacology 20041006
-
Effect of specific phosphodiesterase isoenzyme inhibitors during in vitro maturation of bovine oocytes on meiotic and developmental capacity.
Biology of reproduction 20041001
-
Altered activities of cyclic nucleotide phosphodiesterases and soluble guanylyl cyclase in cultured RFL-6 cells.
The international journal of biochemistry & cell biology 20041001
-
Design, synthesis, and biological evaluation of new phosphodiesterase type 4 inhibitors.
Bioorganic & medicinal chemistry 20041001
-
Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium.
Naunyn-Schmiedeberg's archives of pharmacology 20041001
-
The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
Behavioural brain research 20040923
-
Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
European journal of pharmacology 20040913
-
The effect of the indomethacin on phosphodiesterase inhibitors mediated responses in isolated trachea preparations.
Prostaglandins, leukotrienes, and essential fatty acids 20040901
-
Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism.
British journal of pharmacology 20040901
-
Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast, and rolipram.
Acta pharmacologica Sinica 20040901
-
The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20040901
-
Cyclic nucleotide-dependent phosphodiesterases (PDEI) inhibition by muscarinic antagonists in bovine tracheal smooth muscle.
Biochemical pharmacology 20040815
-
The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
Pharmacological research 20040801
-
Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Biochemical pharmacology 20040801
-
Repetitive exposures to nicotine induce a hyper-responsiveness via the cAMP/PKA/CREB signal pathway in Drosophila.
Journal of neurobiology 20040801
-
Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY.
Circulation research 20040723
-
Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
Life sciences 20040702
-
Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists.
The Journal of allergy and clinical immunology 20040701
-
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Journal of pharmacological sciences 20040701
-
Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
Bioorganic & medicinal chemistry letters 20040607
-
Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.
International immunopharmacology 20040601
-
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury.
Nature medicine 20040601
-
PDE4 inhibitors in COPD--a more selective approach to treatment.
Respiratory medicine 20040601
-
Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
The Journal of pharmacy and pharmacology 20040601
-
Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent.
Journal of neurophysiology 20040501
-
Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89.
The Journal of pharmacology and experimental therapeutics 20040501
-
Augmentation of lipolysis in adipocytes from fed rats, but not from starved rats, by inhibition of rolipram-sensitive phosphodiesterase 4.
Archives of biochemistry and biophysics 20040501
-
Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20040501
-
PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration.
Journal of cell science 20040501
-
The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
The European journal of neuroscience 20040501
-
Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Blood 20040401
-
Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
Journal of molecular biology 20040319
-
Pharmacological inhibition of Mannheimia haemolytica lipopolysaccharide and leukotoxin-induced cytokine expression in bovine alveolar macrophages.
Microbial pathogenesis 20040301
-
Synthesis and biological evaluation of neutrophilic inflammation inhibitors.
Farmaco (Societa chimica italiana : 1989) 20040301
-
[Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates indomethacin-induced gastric mucosal injury in rats].
Nihon rinsho. Japanese journal of clinical medicine 20040301
-
Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion.
Brain research 20040213
-
Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
Biology of reproduction 20040201
-
Antidiuretic hormone resistance in the neonatal cortical collecting tubule is mediated in part by elevated phosphodiesterase activity.
American journal of physiology. Renal physiology 20040201
-
Inhibitory effects of group II mGluR-related drugs on memory performance in mice.
Physiology & behavior 20040201
-
Rho GTPases and phosphoinositide 3-kinase organize formation of branched dendrites.
The Journal of biological chemistry 20040102
-
Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
British journal of pharmacology 20040101
-
Impact of cAMP on the T-cell response to type II collagen.
Immunology 20040101
-
Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
The Journal of clinical endocrinology and metabolism 20040101
-
Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20040101
-
Development of an in vitro model for vascular injury with human endothelial cells.
ALTEX 20040101
-
Beta2-integrin adhesion caused by eotaxin but not IL-5 is blocked by PDE-4 inhibition and beta2-adrenoceptor activation in human eosinophils.
Pulmonary pharmacology & therapeutics 20040101
-
Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.
Neuroscience 20040101
-
Phosphoinositide 3-kinase is involved in Xenopus and Labrus melanophore aggregation.
Cellular signalling 20031201
-
Different regulation of adenylyl cyclase and rolipram-sensitive phosphodiesterase activity on the frontal cortex and hippocampus in learned helplessness rats.
Brain research 20031121
-
Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.
British journal of pharmacology 20031101
-
Lidocaine enhances Galphai protein function.
Anesthesiology 20031101
-
Basal nitric oxide modulates vascular effects of a peptide activating protease-activated receptor 2.
Cardiovascular research 20031101
-
Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
Cellular signalling 20031001
-
Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
The Journal of pharmacology and experimental therapeutics 20031001
-
PDE4D plays a critical role in the control of airway smooth muscle contraction.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20031001
-
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
American journal of respiratory cell and molecular biology 20030901
-
Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7.
Cellular signalling 20030901
-
Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2.
The Journal of biological chemistry 20030829
-
Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.
The Journal of allergy and clinical immunology 20030801
-
Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors.
Bioorganic & medicinal chemistry letters 20030721
-
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics.
Bioorganic & medicinal chemistry letters 20030721
-
Regulation of the cAMP-elevating effects of isoproterenol and forskolin in cardiac myocytes by treatments that cause increases in cAMP.
Biochemical and biophysical research communications 20030718
-
Effect of phosphodiesterase type 4 on circadian clock gene Per1 transcription.
Biochemical and biophysical research communications 20030704
-
Comparative actions of diazepam and other phosphodiesterase inhibitors on the effects of noradrenaline in rat myocardium.
Pharmacology & toxicology 20030701
-
Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity.
Structure (London, England : 1993) 20030701
-
Gamma-lactam synthesis via C-H insertion: elaboration of N-benzyl protecting groups for high regioselectivity toward the total synthesis of rolipram.
Organic letters 20030626
-
Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils.
Intensive care medicine 20030601
-
Theophylline attenuates the adhesion of eosinophils to endothelial cells.
International archives of allergy and immunology 20030601
-
Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase.
Medical science monitor : international medical journal of experimental and clinical research 20030601
-
PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A.
Blood 20030515
-
Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
The Journal of pharmacology and experimental therapeutics 20030501
-
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Carcinogenesis 20030501
-
Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates indomethacin-induced gastric mucosal injury in rats.
Pathophysiology : the official journal of the International Society for Pathophysiology 20030501
-
Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain.
Journal of neural transmission (Vienna, Austria : 1996) 20030401
-
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood.
Journal of veterinary pharmacology and therapeutics 20030401
-
[Physiopathology of COPD: choosing the right therapeutic targets].
Revue de pneumologie clinique 20030401
-
Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
Transplantation 20030327
-
Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
European journal of anaesthesiology 20030301
-
Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma.
British journal of pharmacology 20030301
-
Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein.
Cardiovascular research 20030101
-
Effect of the phosphodiesterase 4 inhibitor, rolipram, on retinoic acid-increased alkaline phosphatase activity in the mouse fibroblastic C3H10T1/2 cell line.
Archives of oral biology 20030101
-
Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294.
Pulmonary pharmacology & therapeutics 20030101
-
Later developments: molecular keys to age-related memory impairment.
Alzheimer disease and associated disorders 20030101
-
Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Arthritis research & therapy 20030101
-
AQP3, p-AQP2, and AQP2 expression is reduced in polyuric rats with hypercalcemia: prevention by cAMP-PDE inhibitors.
American journal of physiology. Renal physiology 20021201
-
Use of near-infrared reflection spectroscopy to study the effects of X-ray contrast media on renal tolerance in rats: effects of a prostacyclin analogue and of phosphodiesterase inhibitors.
Investigative radiology 20021201
-
Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20021115
-
Development of a catalytic enantioselective conjugate addition of 1,3-dicarbonyl compounds to nitroalkenes for the synthesis of endothelin-A antagonist ABT-546. Scope, mechanism, and further application to the synthesis of the antidepressant rolipram.
Journal of the American Chemical Society 20021106
-
Inhibition of human phosphodiesterase 4A expressed in yeast cell GL62 by theophylline, rolipram, and acetamide-45.
Acta pharmacologica Sinica 20021101
-
Enhancement of the relative uptake of 18F-FDG in mouse fibrosarcoma by rolipram.
Annals of nuclear medicine 20021101
-
Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021001
-
Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices.
Brain research 20020913
-
The effects of cAMP modulation upon the adhesion and respiratory burst activity of immune complex-stimulated equine neutrophils.
Veterinary immunology and immunopathology 20020906
-
A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.
Bioorganic & medicinal chemistry letters 20020902
-
Rolipram depresses [(3)H]2-deoxyglucose uptake in mouse brain and heart in vivo.
European journal of nuclear medicine and molecular imaging 20020901
-
Effects of rolipram on in vivo dopamine receptor binding.
Journal of neural transmission (Vienna, Austria : 1996) 20020901
-
Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
Cardiovascular drugs and therapy 20020901
-
Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.
Cytokine 20020821
-
Benefit of phosphodiesterase 4 inhibitors as supplemental therapy after lung transplantation concerning their antiproliferative effects: an experimental study using a heterotopic rodent model.
Transplantation 20020815
-
Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro.
Human reproduction (Oxford, England) 20020801
-
Changes in phosphodiesterase activity in the developing rat submandibular gland.
Archives of oral biology 20020801
-
Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.
The Journal of pharmacology and experimental therapeutics 20020701
-
Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
The Journal of pharmacology and experimental therapeutics 20020701
-
Airway function, oedema, cell infiltration and nitric oxide generation in conscious ozone-exposed guinea-pigs: effects of dexamethasone and rolipram.
British journal of pharmacology 20020701
-
Crystal structure of 5-t-butoxycarbonyl-1-benzoyl-2-pyrrolidinone, an intermediate in the synthesis of (-)-rolipram.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20020701
-
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
Bioorganic & medicinal chemistry letters 20020617
-
Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones.
Journal of medicinal chemistry 20020606
-
Phosphodiesterase type 4 inhibitor reduces the retention of polymorphonuclear leukocytes in the lung.
American journal of physiology. Lung cellular and molecular physiology 20020601
-
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
British journal of pharmacology 20020601
-
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.
Naunyn-Schmiedeberg's archives of pharmacology 20020601
-
Relaxation induced by milrinone and rolipram in human penile arteries and veins.
European journal of pharmacology 20020524
-
Functional plasticity of cyclic AMP hydrolysis in rat adenohypophysial corticotroph cells.
Cellular signalling 20020501
-
Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C.
The Journal of pharmacology and experimental therapeutics 20020501
-
Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human acute lymphoblastic leukemia cells.
Blood 20020501
-
Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
British journal of pharmacology 20020501
-
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20020501
-
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
The Journal of biological chemistry 20020419
-
Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
Naunyn-Schmiedeberg's archives of pharmacology 20020401
-
Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids.
Toxicology and applied pharmacology 20020401
-
Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro.
Diseases of the colon and rectum 20020401
-
Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization.
American journal of physiology. Heart and circulatory physiology 20020301
-
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors.
Bioorganic & medicinal chemistry letters 20020225
-
Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Biochemical pharmacology 20020215
-
Involvement of phosphodiesterase isozymes in osteoblastic differentiation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020201
-
The effects of intravenous anesthetics and lidocaine on proliferation of cultured type II pneumocytes and lung fibroblasts.
Anesthesia and analgesia 20020201
-
Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20020201
-
Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor.
Biological & pharmaceutical bulletin 20020201
-
Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux.
Biochemical and biophysical research communications 20020118
-
Phthalazine PDE4 inhibitors. Part 3: the synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor.
Bioorganic & medicinal chemistry letters 20020107
-
Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse.
Journal of cardiovascular pharmacology 20020101
-
Peptidergic and nitrergic inhibitory neurotransmissions in the hamster jejunum: regulation of vasoactive intestinal peptide release by nitric oxide.
Neuroscience 20020101
-
Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
Proceedings of the Western Pharmacology Society 20020101
-
Facilitation of dopaminergic neural transmission does not affect [(11)C]SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D(1) receptors: PET studies in the conscious monkey brain.
Synapse (New York, N.Y.) 20011215
-
Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.
Clinical and experimental immunology 20011201
-
cAMP-elevating agents suppress dendritic cell function.
Journal of leukocyte biology 20011201
-
Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.
European journal of pharmacology 20011102
-
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
The Journal of pharmacology and experimental therapeutics 20011101
-
Differential phosphodiesterase activity contributes to restrictive endothelial barrier function during angiogenesis.
Microvascular research 20011101
-
The kinetics, function, and regulation of P-selectin expressed by human brain microvessel endothelial cells in primary culture.
Microvascular research 20011101
-
Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
British journal of pharmacology 20011101
-
Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
Psychopharmacology 20011101
-
Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis.
Leukemia 20011001
-
Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.
British journal of pharmacology 20010901
-
Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
British journal of pharmacology 20010901
-
Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.
Biochemistry 20010828
-
Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.
Life sciences 20010824
-
First highly regio- and diastereoselective [3+2] cycloaddition of chiral nonracemic Fischer carbene complexes with azomethine ylides: an enantioselective synthesis of (+)-rolipram.
Chemistry (Weinheim an der Bergstrasse, Germany) 20010817
-
Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
Journal of immunology (Baltimore, Md. : 1950) 20010815
-
Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones.
Journal of medicinal chemistry 20010802
-
Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.
The Journal of urology 20010801
-
Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism.
British journal of pharmacology 20010801
-
Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production.
Laboratory investigation; a journal of technical methods and pathology 20010801
-
Synthesis and structure-activity relationship of N-arylrolipram derivatives as inhibitors of PDE4 isozymes.
Chemical & pharmaceutical bulletin 20010801
-
Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors.
Journal of veterinary pharmacology and therapeutics 20010801
-
Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea pigs: effect of rolipram and dexamethasone.
The Journal of pharmacology and experimental therapeutics 20010701
-
Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
British journal of pharmacology 20010701
-
Vasodilator responses to ATP and UTP are cAMP dependent in the mesenteric vascular bed of the cat.
Journal of cardiovascular pharmacology and therapeutics 20010701
-
Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway.
General and comparative endocrinology 20010601
-
Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Kidney international 20010601
-
Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
Cellular signalling 20010601
-
Maintenance of cAMP in non-heart-beating donor lungs reduces ischemia-reperfusion injury.
American journal of respiratory and critical care medicine 20010601
-
Role of cyclic nucleotide phosphodiesterase isoenzymes in contractile responses of denuded rat aorta related to various Ca2+ sources.
Naunyn-Schmiedeberg's archives of pharmacology 20010601
-
Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells.
Mediators of inflammation 20010601
-
Rolipram reduces excitotoxic neuronal damage.
Neuroreport 20010525
-
Characterization of r-[11C]rolipram for PET imaging of phosphodieterase-4: in vivo binding, metabolism, and dosimetry studies in rats.
Nuclear medicine and biology 20010501
-
Design of rolipram-loaded nanoparticles: comparison of two preparation methods.
Journal of controlled release : official journal of the Controlled Release Society 20010428
-
Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
European journal of pharmacology 20010406
-
Effects of phosphodiesterase inhibitors on hypoxic pulmonary vasoconstriction. Influence of K(+) channels and nitric oxide.
European journal of pharmacology 20010406
-
Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
Clinical and experimental pharmacology & physiology 20010401
-
Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
Cellular signalling 20010401
-
Buchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms.
The Journal of pharmacy and pharmacology 20010401
-
Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
Biochimica et biophysica acta 20010319
-
Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.
Bioorganic & medicinal chemistry letters 20010312
-
Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
British journal of pharmacology 20010301
-
Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Cellular signalling 20010301
-
The influence of phosphodiesterase inhibitor, rolipram, on hemodynamics in lipopolysaccharide-treated rats.
Japanese journal of pharmacology 20010301
-
Structure-activity relationships of quinazoline derivatives: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
Bioorganic & medicinal chemistry letters 20010226
-
Inflammation contributes to the postponed ischemic neuronal damage following treatment with a glutamate antagonist in rats.
Neuroscience letters 20010202
-
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
Clinical immunology (Orlando, Fla.) 20010201
-
Phthalazine PDE4 inhibitors. Part 2: the synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives.
Bioorganic & medicinal chemistry letters 20010108
-
A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice.
Behavioural brain research 20010108
-
PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway.
Neuropharmacology 20010101
-
Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010101
-
Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge.
American journal of respiratory and critical care medicine 20010101
-
[Suppression of synthesis of tumor necrosis factor].
Der Internist 20010101
-
Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia.
Pulmonary pharmacology & therapeutics 20010101
-
[Inhibition of uterine contractions: new in vitro pharmacological approaches on the pregnant human myometrium].
Therapie 20010101
-
The antidepressant and antiinflammatory effects of rolipram in the central nervous system.
CNS drug reviews 20010101
-
Effects of several glucocorticosteroids and PDE4 inhibitors on increases in total lung eosinophil peroxidase (EPO) levels following either systemic or intratracheal administration in sephadex- or ovalbumin-induced inflammatory models.
Inflammation 20000801
-
Use of an activation-specific probe to show that Rap1A and Rap1B display different sensitivities to activation by forskolin in rat1 cells.
FEBS letters 20000721
-
beta-Adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils.
Naunyn-Schmiedeberg's archives of pharmacology 20000401
-
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
British journal of pharmacology 19990601
-
The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform.
The Journal of biological chemistry 19990521
-
SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
The Journal of pharmacology and experimental therapeutics 19981101
-
Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors.
The Journal of allergy and clinical immunology 19981101
-
Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism.
British journal of pharmacology 19981101
-
Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
Journal of virology 19980601
-
SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.
The Journal of pharmacology and experimental therapeutics 19980101
-
CDP840: a novel inhibitor of PDE-4.
Cell biochemistry and biophysics 19980101
-
Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition.
The Journal of clinical investigation 19971001
-
Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D.
Biochemical and biophysical research communications 19970519
-
The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.
British journal of pharmacology 19961101
-
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
The Journal of neuroscience : the official journal of the Society for Neuroscience 19960401
-
Delayed sympathectomy after a prolonged hyperalgesia results in a subsequent enhanced acute hyperalgesic response.
Neuroscience 19960401
-
Action of cAMP on expression and release of adhesion molecules in human endothelial cells.
The American journal of physiology 19960301
-
Dipyridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells.
European journal of pharmacology 19960205
-
Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
Cellular signalling 19960201
-
Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
AIDS (London, England) 19951001
-
Studies on anti-allergic action of AH 21-132, a novel isozyme-selective phosphodiesterase inhibitor in airways.
Japanese journal of pharmacology 19950201
-
Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat.
Neuroscience 19950201
-
Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin.
Peptides 19950101
-
Central and peripheral minocycline suppresses motor activity in rats.
Pharmacology, biochemistry, and behavior 19930201
-
Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia.
Neuroscience 19910101
-
Adenosine receptor antagonism accounts for the seizure-prolonging effects of aminophylline.
Pharmacology, biochemistry, and behavior 19900801
-
Caffeine and panic attacks.
The British journal of psychiatry : the journal of mental science 19870501